Minimally Invasive Liver Surgery for Metastases From Colorectal Cancer: Oncologic Outcome and Prognostic Factors

University Hospital, Gasthuisberg

Status: Completed

Conditions: Long-term Oncologic Outcome of MILS in Patients With CRLM and Prognostic Indicators

Study type: Observational

Funder types: Other

Identifiers

NCT01356706

CRLM-MILS

Details and patient eligibility

About

Only few reports exist on long-term survival after minimally invasive liver surgery (MILS for colorectal liver metastases. No data are available assessing prognostic factors in the era of current modern treatment strategies. The aim of the current study is to analyze the long-term oncologic outcome after MILS for metastases from colorectal cancer and determine prognostic indicators.

Enrollment: 274 patients

Sex: All

Ages: 18 to 90 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients with CRLM
• Surgery: resection and/or ablation
• preoperative chemotherapy and/or biological agents are allowed
• postoperative chemotherapy and/or biological agents are allowed
• simultaneous colorectal resection is allowed

Exclusion criteria

• primary liver cancer
• benign liver tumors
• pregnancy

Trial design

274 participants in 1 patient group

CRLM

Description:

patients with colorectal liver metastases (CRLM) who undergo their primary surgery at UZ. Leuven (single-center academic study)